Kezar Life Sciences to Present at the 41st Annual J.P. Morgan Healthcare Conference

Author's Avatar
Jan 04, 2023

Kezar+Life+Sciences%2C+Inc. (Nasdaq: KZR), a clinical-stage biotechnology company discovering and developing breakthrough treatments for immune-mediated and oncologic disorders, today announced that John Fowler, Co-founder and Chief Executive Officer, will present a corporate overview at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023 at 2:15 pm PT in San Francisco, CA.